Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriella L. Boulting is active.

Publication


Featured researches published by Gabriella L. Boulting.


Cell | 2011

Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines

Christoph Bock; Evangelos Kiskinis; Griet Verstappen; Hongcang Gu; Gabriella L. Boulting; Zachary D. Smith; Michael J. Ziller; Gist F. Croft; Mackenzie W. Amoroso; Derek Oakley; Andreas Gnirke; Kevin Eggan; Alexander Meissner

The developmental potential of human pluripotent stem cells suggests that they can produce disease-relevant cell types for biomedical research. However, substantial variation has been reported among pluripotent cell lines, which could affect their utility and clinical safety. Such cell-line-specific differences must be better understood before one can confidently use embryonic stem (ES) or induced pluripotent stem (iPS) cells in translational research. Toward this goal we have established genome-wide reference maps of DNA methylation and gene expression for 20 previously derived human ES lines and 12 human iPS cell lines, and we have measured the in vitro differentiation propensity of these cell lines. This resource enabled us to assess the epigenetic and transcriptional similarity of ES and iPS cells and to predict the differentiation efficiency of individual cell lines. The combination of assays yields a scorecard for quick and comprehensive characterization of pluripotent cell lines.


Nature Biotechnology | 2011

A functionally characterized test set of human induced pluripotent stem cells.

Gabriella L. Boulting; Evangelos Kiskinis; Gist F. Croft; Mackenzie W. Amoroso; Derek Oakley; Brian J. Wainger; Damian J. Williams; David J. Kahler; Mariko Yamaki; Lance S. Davidow; Christopher T Rodolfa; John T. Dimos; Shravani Mikkilineni; Amy B. MacDermott; Clifford J. Woolf; Christopher E. Henderson; Hynek Wichterle; Kevin Eggan

Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications.


Cell Stem Cell | 2008

Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation

Francesco Paolo Di Giorgio; Gabriella L. Boulting; Samuel Bobrowicz; Kevin Eggan

It has been proposed that human embryonic stem cells could be used to provide an inexhaustible supply of differentiated cell types for the study of disease processes. Although methods for differentiating embryonic stem cells into specific cell types have become increasingly sophisticated, the utility of the resulting cells for modeling disease has not been determined. We have asked whether specific neuronal subtypes produced from human embryonic stem cells can be used to investigate the mechanisms leading to neural degeneration in amyotrophic lateral sclerosis (ALS). We show that human spinal motor neurons, but not interneurons, are selectively sensitive to the toxic effect of glial cells carrying an ALS-causing mutation in the SOD1 gene. Our findings demonstrate the relevance of these non-cell-autonomous effects to human motor neurons and more broadly demonstrate the utility of human embryonic stem cells for studying disease and identifying potential therapeutics.


Cell Reports | 2014

Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

Brian J. Wainger; Evangelos Kiskinis; Cassidy Mellin; Ole Wiskow; Steve S.W. Han; Jackson Sandoe; Numa P. Perez; Luis A. Williams; Seungkyu Lee; Gabriella L. Boulting; James D. Berry; Robert H. Brown; Merit Cudkowicz; Bruce P. Bean; Kevin Eggan; Clifford J. Woolf

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor nervous system. We show using multielectrode array and patch-clamp recordings that hyperexcitability detected by clinical neurophysiological studies of ALS patients is recapitulated in induced pluripotent stem cell-derived motor neurons from ALS patients harboring superoxide dismutase 1 (SOD1), C9orf72, and fused-in-sarcoma mutations. Motor neurons produced from a genetically corrected but otherwise isogenic SOD1(+/+) stem cell line do not display the hyperexcitability phenotype. SOD1(A4V/+) ALS patient-derived motor neurons have reduced delayed-rectifier potassium current amplitudes relative to control-derived motor neurons, a deficit that may underlie their hyperexcitability. The Kv7 channel activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS cases. Therefore, electrophysiological characterization of human stem cell-derived neurons can reveal disease-related mechanisms and identify therapeutic candidates.


Nature Methods | 2014

All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins

Daniel Hochbaum; Yongxin Zhao; Samouil L Farhi; Nathan Cao Klapoetke; Christopher A. Werley; Vikrant Kapoor; Peng Zou; Joel M. Kralj; Dougal Maclaurin; Niklas Smedemark-Margulies; Jessica L. Saulnier; Gabriella L. Boulting; Christoph Straub; Yong Ku Cho; Michael Melkonian; Gane Ka-Shu Wong; Venkatesh N. Murthy; Bernardo L. Sabatini; Edward S. Boyden; Robert E. Campbell; Adam E. Cohen

All-optical electrophysiology—spatially resolved simultaneous optical perturbation and measurement of membrane voltage—would open new vistas in neuroscience research. We evolved two archaerhodopsin-based voltage indicators, QuasAr1 and QuasAr2, which show improved brightness and voltage sensitivity, have microsecond response times and produce no photocurrent. We engineered a channelrhodopsin actuator, CheRiff, which shows high light sensitivity and rapid kinetics and is spectrally orthogonal to the QuasArs. A coexpression vector, Optopatch, enabled cross-talk–free genetically targeted all-optical electrophysiology. In cultured rat neurons, we combined Optopatch with patterned optical excitation to probe back-propagating action potentials (APs) in dendritic spines, synaptic transmission, subcellular microsecond-timescale details of AP propagation, and simultaneous firing of many neurons in a network. Optopatch measurements revealed homeostatic tuning of intrinsic excitability in human stem cell–derived neurons. In rat brain slices, Optopatch induced and reported APs and subthreshold events with high signal-to-noise ratios. The Optopatch platform enables high-throughput, spatially resolved electrophysiology without the use of conventional electrodes.


Cell Stem Cell | 2014

Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1

Evangelos Kiskinis; Jackson Sandoe; Luis A. Williams; Gabriella L. Boulting; Rob Moccia; Brian J. Wainger; Steve S.W. Han; Theodore Peng; Sebastian Thams; Shravani Mikkilineni; Cassidy Mellin; Florian T. Merkle; Brandi N. Davis-Dusenbery; Michael J. Ziller; Derek Oakley; Justin K. Ichida; Stefania Di Costanzo; Nick Atwater; Morgan L. Maeder; Mathew J. Goodwin; James Nemesh; Robert E. Handsaker; Daniel Paull; Scott Noggle; Steven A. McCarroll; J. Keith Joung; Clifford J. Woolf; Robert H. Brown; Kevin Eggan

Although many distinct mutations in a variety of genes are known to cause Amyotrophic Lateral Sclerosis (ALS), it remains poorly understood how they selectively impact motor neuron biology and whether they converge on common pathways to cause neuronal degeneration. Here, we have combined reprogramming and stem cell differentiation approaches with genome engineering and RNA sequencing to define the transcriptional and functional changes that are induced in human motor neurons by mutant SOD1. Mutant SOD1 protein induced a transcriptional signature indicative of increased oxidative stress, reduced mitochondrial function, altered subcellular transport, and activation of the ER stress and unfolded protein response pathways. Functional studies demonstrated that these pathways were perturbed in a manner dependent on the SOD1 mutation. Finally, interrogation of stem-cell-derived motor neurons produced from ALS patients harboring a repeat expansion in C9orf72 indicates that at least a subset of these changes are more broadly conserved in ALS.


Molecular Therapy | 2011

Rapid and Efficient Generation of Functional Motor Neurons From Human Pluripotent Stem Cells Using Gene Delivered Transcription Factor Codes

Mark Hester; Matthew J. Murtha; SungWon Song; Meghan Rao; Carlos J. Miranda; Kathrin Meyer; Jinbin Tian; Gabriella L. Boulting; David V. Schaffer; Michael X. Zhu; Samuel L. Pfaff; Fred H. Gage; Brian K. Kaspar

Stem cell-derived motor neurons (MNs) are increasingly utilized for modeling disease in vitro and for developing cellular replacement strategies for spinal cord injury and diseases such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Human embryonic stem cell (hESC) differentiation into MNs, which involves retinoic acid (RA) and activation of the sonic hedgehog (SHH) pathway is inefficient and requires up to 60 days to develop MNs with electrophysiological properties. This prolonged differentiation process has hampered the use of hESCs, in particular for high-throughput screening. We evaluated the MN gene expression profile of RA/SHH-differentiated hESCs to identify rate-limiting factors involved in MN development. Based on this analysis, we developed an adenoviral gene delivery system encoding for MN inducing transcription factors: neurogenin 2 (Ngn2), islet-1 (Isl-1), and LIM/homeobox protein 3 (Lhx3). Strikingly, delivery of these factors induced functional MNs with mature electrophysiological properties, 11-days after gene delivery, with >60-70% efficiency from hESCs and human induced pluripotent stem cells (hiPSCs). This directed programming approach significantly reduces the time required to generate electrophysiologically-active MNs by approximately 30 days in comparison to conventional differentiation techniques. Our results further exemplify the potential to use transcriptional coding for rapid and efficient production of defined cell types from hESCs and hiPSCs.


Protein Science | 2005

Crystallization of bacteriorhodopsin from bicelle formulations at room temperature.

Salem Faham; Gabriella L. Boulting; Elizabeth A. Massey; Sarah Yohannan; Dawn Yang; James U. Bowie

We showed previously that high‐quality crystals of bacteriorhodopsin (bR) from Halobacterium salinarum can be obtained from bicelle‐forming DMPC/CHAPSO mixtures at 37°C. As many membrane proteins are not sufficiently stable for crystallization at this high temperature, we tested whether the bicelle method could be applied at a lower temperature. Here we show that bR can be crystallized at room temperature using two different bicelle‐forming compositions: DMPC/CHAPSO and DTPC/CHAPSO. The DTPC/CHAPSO crystals grown at room temperature are essentially identical to the previous, twinned crystals: space group P21 with unit cell dimensions of a = 44.7 Å, b = 108.7 Å, c = 55.8 Å, β = 113.6°. The room‐temperature DMPC/CHAPSO crystals are untwinned, however, and belong to space group C2221 with the following unit cell dimensions: a = 44.7 Å, b = 102.5 Å, c = 128.2 Å. The bR protein packs into almost identical layers in the two crystal forms, but the layers stack differently. The new untwinned crystal form yielded clear density for a previously unresolved CHAPSO molecule inserted between protein subunits within the layers. The ability to grow crystals at room temperature significantly expands the applicability of bicelle crystallization.


Protein Science | 2009

Genetic selection system for improving recombinant membrane protein expression in E. coli

Elizabeth Massey-Gendel; Anni Zhao; Gabriella L. Boulting; Hye-Yeon Kim; Michael A. Balamotis; Len M. Seligman; Robert K. Nakamoto; James U. Bowie

A major barrier to the physical characterization and structure determination of membrane proteins is low yield in recombinant expression. To address this problem, we have designed a selection strategy to isolate mutant strains of Escherichia coli that improve the expression of a targeted membrane protein. In this method, the coding sequence of the membrane protein of interest is fused to a C‐terminal selectable marker, so that the production of the selectable marker and survival on selective media is linked to expression of the targeted membrane protein. Thus, mutant strains with improved expression properties can be directly selected. We also introduce a rapid method for curing isolated strains of the plasmids used during the selection process, in which the plasmids are removed by in vivo digestion with the homing endonuclease I‐CreI. We tested this selection system on a rhomboid family protein from Mycobacterium tuberculosis (Rv1337) and were able to isolate mutants, which we call EXP strains, with up to 75‐fold increased expression. The EXP strains also improve the expression of other membrane proteins that were not the target of selection, in one case roughly 90‐fold.


Nature | 2016

Evolution of Osteocrin as an activity-regulated factor in the primate brain

Gabriella L. Boulting; David A. Harmin; Marty G. Yang; Mollie Baker-Salisbury; Ee Lynn Yap; Athar N. Malik; Kevin Mei; Alex A. Rubin; Ivo Spiegel; Ershela Durresi; Nikhil Sharma; Linda Hu; Mihovil Pletikos; Eric C. Griffith; Jennifer N. Partlow; Christine Stevens; Mazhar Adli; Maria H. Chahrour; Nenad Sestan; Christopher A. Walsh; Vladimir K. Berezovskii; Margaret S. Livingstone; Michael E. Greenberg

Sensory stimuli drive the maturation and function of the mammalian nervous system in part through the activation of gene expression networks that regulate synapse development and plasticity. These networks have primarily been studied in mice, and it is not known whether there are species- or clade-specific activity-regulated genes that control features of brain development and function. Here we use transcriptional profiling of human fetal brain cultures to identify an activity-dependent secreted factor, Osteocrin (OSTN), that is induced by membrane depolarization of human but not mouse neurons. We find that OSTN has been repurposed in primates through the evolutionary acquisition of DNA regulatory elements that bind the activity-regulated transcription factor MEF2. In addition, we demonstrate that OSTN is expressed in primate neocortex and restricts activity-dependent dendritic growth in human neurons. These findings suggest that, in response to sensory input, OSTN regulates features of neuronal structure and function that are unique to primates.

Collaboration


Dive into the Gabriella L. Boulting's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clifford J. Woolf

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cassidy Mellin

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James U. Bowie

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert H. Brown

University of Massachusetts Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge